HBSP (USA)
-
BeiGene
Shih, Willy; Zhang, JimmyCase HBS-618033-EStrategyBeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeStarting at €8.20
-
BeiGene, PowerPoint Supplement
Shih, Willy; Zhang, JimmyCase HBS-618043-EStrategyPowerPoint slides for case 618033.Starting at €8.20
-
BeiGene, Teaching Note
Shih, Willy; Zhang, JimmyTeaching Note HBS-618039-EStrategyTeaching Note for 618033 BeiGene. BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window of opportunity to develop drug candidates toward known targets with known mechanisms of actions that would allow it to become first-in-class in Ch...Starting at €0.00
-
Shang Xia: The Creation of a Chinese Luxury Lifestyle Brand
Keinan, Anat; Crener, Sandrine; Xu, Jing; Borgerson, Janet; Schroeder, Jonathan; Wu, ZhiyanCase HBS-517032-EMarketingThe case traces the birth of Shang Xia, a joint venture between the Herm s Group and Chinese designer Jiang Qiong Er. Launched in 2009 in Shanghai, the new brand's core mission is to revive and promote China's 5,000-year-old cultural heritage and leverage Chinese craftsmanship to design contemporary products. Describing the brand evolution over its first eight years of existence, the case allows for an exploration of the challenges associated wi...Starting at €8.20